olmesartan

(Cardiovascular Research Foundation) Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics scientific symposium, sponsored by the Cardiovascular Research Foundation, suggests that olmesartan, a drug commonly used to treat high blood pressure, may play a role in reducing coronary plaque.